Management of Coats disease with bevacizumab in 2 patients
- 1 April 2008
- journal article
- Published by Elsevier in Canadian Journal of Ophthalmology
- Vol. 43 (2) , 245-246
- https://doi.org/10.3129/i08-028
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Findings in Fluorescein Angiography and Optical Coherence Tomography after Intravitreal Bevacizumab in Type 2 Idiopathic Macular TelangiectasiaOphthalmology, 2007
- Elevated vascular endothelial growth factor levels in Coats disease: rapid response to pegaptanib sodiumAlbrecht von Graefes Archiv für Ophthalmologie, 2007
- INTRAVITREAL BEVACIZUMAB (AVASTIN) THERAPY FOR PERSISTENT DIFFUSE DIABETIC MACULAR EDEMARetina, 2006
- RAPID IMPROVEMENT OF RUBEOSIS IRIDIS FROM A SINGLE BEVACIZUMAB (AVASTIN) INJECTIONRetina, 2006
- Coats’ DiseaseInternational Ophthalmology Clinics, 2001
- Coats' syndrome: long term follow upBritish Journal of Ophthalmology, 2000
- Electron microscopical study of Coat's disease.British Journal of Ophthalmology, 1971